معرفی
Christel Van Geet is a full professor at the Faculty of Medicine of KU Leuven, affiliated with the Center for Molecular and Vascular Biology and the KU Leuven Cancer Institute. She leads research on genetic mechanisms underlying bleeding disorders, thrombosis, and platelet dysfunction, with a focus on genomic medicine and translational hematology.
- Blood group O and inhibitor risk in haemophilia A
- β-globin haplotypes in sickle cell anemia
- Ribosome dysfunction in thrombocytopenia
- Clinical implementation of genetic testing
Her work spans molecular biology, clinical diagnostics, and global health initiatives in Central Africa. She collaborates extensively in international consortia like PedNet and contributes to advancing gene-based therapies such as emicizumab for hemophilia.
۰مقاله منتشرشده
